These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21768164)

  • 1. Effect of multiple infection of cells on the evolutionary dynamics of HIV in vivo: implications for host adaptation mechanisms.
    Wodarz D; Levy DN
    Exp Biol Med (Maywood); 2011 Aug; 236(8):926-37. PubMed ID: 21768164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple HIV-1 infection of cells and the evolutionary dynamics of cytotoxic T lymphocyte escape mutants.
    Wodarz D; Levy DN
    Evolution; 2009 Sep; 63(9):2326-39. PubMed ID: 19486149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the intra-host dynamics of HIV-1 infections.
    Stilianakis NI; Schenzle D
    Math Biosci; 2006 Jan; 199(1):1-25. PubMed ID: 16343556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does cytolysis by CD8+ T cells drive immune escape in HIV infection?
    Balamurali M; Petravic J; Loh L; Alcantara S; Kent SJ; Davenport MP
    J Immunol; 2010 Nov; 185(9):5093-101. PubMed ID: 20881189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV escape: there and back again.
    Altman JD; Feinberg MB
    Nat Med; 2004 Mar; 10(3):229-30. PubMed ID: 14991039
    [No Abstract]   [Full Text] [Related]  

  • 6. New insights into the immunology and evolution of HIV.
    Stebbing J; Patterson S; Gotch F
    Cell Res; 2003 Feb; 13(1):1-7. PubMed ID: 12643344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
    Kent SJ; Fernandez CS; Dale CJ; Davenport MP
    Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
    Oxenius A; Price DA; Trkola A; Edwards C; Gostick E; Zhang HT; Easterbrook PJ; Tun T; Johnson A; Waters A; Holmes EC; Phillips RE
    J Infect Dis; 2004 Aug; 190(4):713-21. PubMed ID: 15272399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor.
    Barker E
    J Infect Dis; 1999 May; 179 Suppl 3():S485-8. PubMed ID: 10099125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of HIV-1 determinants for replication in vivo.
    Su L; Kaneshima H; Bonyhadi ML; Lee R; Auten J; Wolf A; Du B; Rabin L; Hahn BH; Terwilliger E; Mccune JM
    Virology; 1997 Jan; 227(1):45-52. PubMed ID: 9007057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
    Martinez-Picado J; Martínez MA
    Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease.
    Toossi Z
    J Infect Dis; 2003 Oct; 188(8):1146-55. PubMed ID: 14551885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication rate and evolution in the human immunodeficiency virus.
    Kelly JK
    J Theor Biol; 1996 Jun; 180(4):359-64. PubMed ID: 8776467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of HIV immune escape and reversion: implications for vaccination.
    Davenport MP; Loh L; Petravic J; Kent SJ
    Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation.
    Crotti A; Neri F; Corti D; Ghezzi S; Heltai S; Baur A; Poli G; Santagostino E; Vicenzi E
    J Virol; 2006 Nov; 80(21):10663-74. PubMed ID: 16943296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral dynamics in human immunodeficiency virus type 1 infection.
    Wei X; Ghosh SK; Taylor ME; Johnson VA; Emini EA; Deutsch P; Lifson JD; Bonhoeffer S; Nowak MA; Hahn BH
    Nature; 1995 Jan; 373(6510):117-22. PubMed ID: 7529365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary analysis of human immunodeficiency virus type 1 therapies based on conditionally replicating vectors.
    Ke R; Lloyd-Smith JO
    PLoS Comput Biol; 2012; 8(10):e1002744. PubMed ID: 23133349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Moore CB; John M; James IR; Christiansen FT; Witt CS; Mallal SA
    Science; 2002 May; 296(5572):1439-43. PubMed ID: 12029127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 mutates to adapt in fluxing environments.
    Nomaguchi M; Doi N; Koma T; Adachi A
    Microbes Infect; 2018; 20(9-10):610-614. PubMed ID: 28859896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1-infected T-cells dynamics and prognosis: An evolutionary game model.
    Khazaei B; Sartakhti JS; Manshaei MH; Zhu Q; Sadeghi M; Mousavi SR
    Comput Methods Programs Biomed; 2017 Dec; 152():1-14. PubMed ID: 29054249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.